Ori Biotech and CellGenix Collaborate on Closed-system, Mobile and Gene Treatment Production

Ori Biotech, a London- and Philadelphia-based production era corporate that provides an automatic, closed formulation for cellular and gene treatment (CGT) production, and CellGenix, a provider of uncooked and ancillary fabrics for CGT and regenerative drugs headquartered in Germany, introduced i